Ieq Capital LLC Buys New Shares in Schrodinger, Inc. $SDGR

Ieq Capital LLC bought a new position in shares of Schrodinger, Inc. (NASDAQ:SDGR) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 71,397 shares of the company’s stock, valued at approximately $1,160,000.

Several other large investors have also recently bought and sold shares of SDGR. BlackRock Inc. bought a new position in Schrodinger in the second quarter valued at approximately $170,978,000. Vanguard Group Inc. boosted its holdings in shares of Schrodinger by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 6,464,426 shares of the company’s stock valued at $115,584,000 after buying an additional 125,349 shares during the last quarter. Rubric Capital Management LP boosted its holdings in shares of Schrodinger by 43.8% in the 1st quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company’s stock valued at $68,160,000 after buying an additional 1,828,502 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Schrodinger by 12.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,717,890 shares of the company’s stock valued at $66,476,000 after buying an additional 414,231 shares in the last quarter. Finally, Amova Asset Management Americas Inc. grew its stake in shares of Schrodinger by 13.2% in the first quarter. Amova Asset Management Americas Inc. now owns 3,190,837 shares of the company’s stock valued at $36,248,000 after buying an additional 371,167 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have issued reports on SDGR. Morgan Stanley dropped their price target on shares of Schrodinger from $19.00 to $17.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 14th. UBS Group began coverage on shares of Schrodinger in a research note on Friday, August 14th. They set a “neutral” rating and a $19.00 price objective on the stock. Wall Street Zen upgraded shares of Schrodinger from a “strong sell” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings cut Schrodinger from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, August 12th. Three analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $20.50.

Schrodinger Price Performance

Shares of NASDAQ SDGR opened at $19.47 on Thursday. The stock’s fifty day moving average price is $16.72 and its two-hundred day moving average price is $14.07. Schrodinger, Inc. has a one year low of $10.94 and a one year high of $23.02. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of -26.31 and a beta of 1.63.

Schrodinger (NASDAQ:SDGR) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The firm had revenue of $58.89 million for the quarter, compared to analysts’ expectations of $47.19 million. During the same quarter last year, the business earned ($0.65) EPS. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. On average, equities analysts anticipate that Schrodinger, Inc. will post -1.89 earnings per share for the current fiscal year.

Schrodinger Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.